Joel A Sincavage

Array ( [id] => 4355578 [patent_doc_number] => 06291637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Interference with viral IRES-mediated translation by a small yeast RNA reveals critical RNA-protein interactions' [patent_app_type] => 1 [patent_app_number] => 9/316630 [patent_app_country] => US [patent_app_date] => 1999-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20940 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291637.pdf [firstpage_image] =>[orig_patent_app_number] => 316630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071955 [patent_doc_number] => 06841539 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-11 [patent_title] => 'Compositions and methods for topical delivery of oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/315294 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21652 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841539.pdf [firstpage_image] =>[orig_patent_app_number] => 09315294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1542201 [patent_doc_number] => 06372478 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Recombinant mycobacteria' [patent_app_type] => B1 [patent_app_number] => 09/314207 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 20552 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372478.pdf [firstpage_image] =>[orig_patent_app_number] => 09314207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301821 [patent_doc_number] => 06187585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Oligonucleotide inhibition of epidermal growth factor receptor expression' [patent_app_type] => 1 [patent_app_number] => 9/306876 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7844 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187585.pdf [firstpage_image] =>[orig_patent_app_number] => 306876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244190 [patent_doc_number] => 06136547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Nucleic acid molecules encoding glutx and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/299549 [patent_app_country] => US [patent_app_date] => 1999-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29235 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136547.pdf [firstpage_image] =>[orig_patent_app_number] => 299549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1282724 [patent_doc_number] => 06638504 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Methods for treating cancer' [patent_app_type] => B1 [patent_app_number] => 09/298625 [patent_app_country] => US [patent_app_date] => 1999-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 27063 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638504.pdf [firstpage_image] =>[orig_patent_app_number] => 09298625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234323 [patent_doc_number] => 06165788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Antisense modulation of Survivin expression' [patent_app_type] => 1 [patent_app_number] => 9/286407 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18604 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165788.pdf [firstpage_image] =>[orig_patent_app_number] => 286407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152318 [patent_doc_number] => 06107092 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Antisense modulation of SRA expression' [patent_app_type] => 1 [patent_app_number] => 9/280409 [patent_app_country] => US [patent_app_date] => 1999-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29871 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107092.pdf [firstpage_image] =>[orig_patent_app_number] => 280409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1063280 [patent_doc_number] => 06849724 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Method for transforming plant, the resultant plant and gene thereof' [patent_app_type] => utility [patent_app_number] => 09/646825 [patent_app_country] => US [patent_app_date] => 1999-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 9763 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849724.pdf [firstpage_image] =>[orig_patent_app_number] => 09646825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524399 [patent_doc_number] => 06353091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Human N-type calcium channel isoform' [patent_app_type] => B1 [patent_app_number] => 09/268163 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 58109 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353091.pdf [firstpage_image] =>[orig_patent_app_number] => 09268163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674830 [patent_doc_number] => 20030060433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'INHIBITION OF STRESS ACTIVATED PROTEIN KINASE (SAPK) PATHWAY AND SENSITIZATION OF CELLS TO CANCER THERAPIES' [patent_app_type] => new [patent_app_number] => 09/265350 [patent_app_country] => US [patent_app_date] => 1999-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10346 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060433.pdf [firstpage_image] =>[orig_patent_app_number] => 09265350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999313 [patent_doc_number] => 05986078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'DNA sequence encoding the tumor suppressor gene ING1' [patent_app_type] => 1 [patent_app_number] => 9/258371 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 17202 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986078.pdf [firstpage_image] =>[orig_patent_app_number] => 258371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071935 [patent_doc_number] => 05965398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'DNA sequence encoding a tumor suppressor gene' [patent_app_type] => 1 [patent_app_number] => 9/258257 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 9029 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965398.pdf [firstpage_image] =>[orig_patent_app_number] => 258257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406483 [patent_doc_number] => 06238918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'DNA sequence encoding the tumor suppressor gene ING1' [patent_app_type] => 1 [patent_app_number] => 9/258372 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 17355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238918.pdf [firstpage_image] =>[orig_patent_app_number] => 258372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1447258 [patent_doc_number] => 06369196 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Molecules of the card-related protein family and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/245281 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 18 [patent_no_of_words] => 58487 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369196.pdf [firstpage_image] =>[orig_patent_app_number] => 09245281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462185 [patent_doc_number] => 06350581 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Tumor-associated antigen' [patent_app_type] => B1 [patent_app_number] => 09/227224 [patent_app_country] => US [patent_app_date] => 1999-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18433 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350581.pdf [firstpage_image] =>[orig_patent_app_number] => 09227224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314630 [patent_doc_number] => 06316596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Receptor for peptide hormones involving in energy homeostasis' [patent_app_type] => 1 [patent_app_number] => 9/208394 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 18187 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316596.pdf [firstpage_image] =>[orig_patent_app_number] => 208394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284864 [patent_doc_number] => 06268137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Specific inhibitors of DNA methyl transferase' [patent_app_type] => 1 [patent_app_number] => 9/206866 [patent_app_country] => US [patent_app_date] => 1998-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10742 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268137.pdf [firstpage_image] =>[orig_patent_app_number] => 206866 [rel_patent_id] =>[rel_patent_doc_number] =>)